ArticlePloS one2025
The effect of foliar spraying of silver and iron nanoparticles as fertilizers on the quantity, quality, and antimicrobial properties of Melissa officinalis L. essential oil.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melissa officinalis L. as a medicinal plant used in traditional medicine to treat headaches caused by stress, anemia, nausea, dizziness, indigestion, colic, epilepsy, hysteria, cancer, and heart failure. The present study aimed to evaluate the effect of foliar spraying of silver and iron nanoparticles as fertilizers on yield, type, chemical compounds, and antimicrobial properties of M. officinalis leaf essential oil. For this purpose, plant cultivation was conducted in May 2020 as a completely random design. After one year of establishment, foliar spraying was conducted at the beginning of flowering, the peak of flowering, and the end of flowering at the levels of 20, 40, 60, 80, and 100 mg/L, and the control of iron and silver nanoparticles. After collecting and drying the leaves, the essential oil was extracted by water distillation, and the compounds were identified by Gas chromatography-mass spectrometry. The antibacterial activity of essential oils was evaluated by using agar diffusion method, Minimum growth inhibitory concentration, and Minimum concentration of bacterial lethality. The results showed that foliar spraying with different nano iron and silver treatments had a significant effect on the yield, percentage of compounds, and antimicrobial activity of M. officinalis leaf essential oil (p ≤ 0.01). The 60 mg/L of FeNPs concentration with 1.70% (w/w) had the highest yield of M. officinalis leaf essential oil. The neral (33.5-0%), citral (28.53-0%), geranial (28.25-0%), caryophyllene (20.71-0%), caryophyllene-oxide (19.73-7.36%), and geranial acetate (5.99-11.84%) were the dominant compounds of essential oil. The results of antimicrobial test showed that the lowest MIC value belongs to the treatments of nano iron 100, nano silver 20, and nano silver 60 mg/L with a value of <62.5 μg/mL. against Pseudomonas aeruginosa, that it was one times weaker than rifampin and three times more potent than the control treatment. However, the best treatment in terms of of the essential oil efficiency was for the samples sprayed with nanoiron 60 mg/L. In terms of the essential oil componds, was for the nanoiron treatment 100 mg/L with the predominance of caryophyllene oxide and geranyl acetate, and in terms of the antimicrobial activity, was for the nano silver treatment, 60 mg/L. Therefore, they can be promising and potential natural options for the production of M. officinalis essential oil under foliar spraying with economical and environmentally friendly fertilizers for consumption in various pharmaceutical and cosmetic industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.